Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudoxanthoma Elasticum | 25 | 2024 | 32 | 5.590 |
Why?
|
| Calcinosis | 12 | 2024 | 62 | 2.700 |
Why?
|
| ATP-Binding Cassette Transporters | 16 | 2021 | 82 | 2.570 |
Why?
|
| Liver | 8 | 2018 | 511 | 1.320 |
Why?
|
| Diphosphates | 5 | 2025 | 7 | 1.110 |
Why?
|
| Disease Models, Animal | 11 | 2025 | 1596 | 1.050 |
Why?
|
| Pyrophosphatases | 4 | 2021 | 8 | 0.970 |
Why?
|
| Mutation | 8 | 2017 | 1177 | 0.760 |
Why?
|
| Mice | 23 | 2025 | 6644 | 0.760 |
Why?
|
| Mice, Inbred C57BL | 13 | 2025 | 1869 | 0.750 |
Why?
|
| Calcification, Physiologic | 1 | 2021 | 18 | 0.690 |
Why?
|
| Dyslipidemias | 1 | 2021 | 48 | 0.650 |
Why?
|
| Dietary Supplements | 3 | 2025 | 213 | 0.640 |
Why?
|
| Atherosclerosis | 1 | 2021 | 169 | 0.580 |
Why?
|
| Mice, Knockout | 9 | 2024 | 1035 | 0.570 |
Why?
|
| Animals | 27 | 2025 | 16992 | 0.560 |
Why?
|
| beta-Thalassemia | 2 | 2011 | 5 | 0.550 |
Why?
|
| Phenylbutyrates | 2 | 2016 | 5 | 0.540 |
Why?
|
| Heart Injuries | 1 | 2014 | 10 | 0.420 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 2021 | 18 | 0.380 |
Why?
|
| Vitamin K | 1 | 2011 | 9 | 0.350 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 526 | 0.330 |
Why?
|
| Phenotype | 6 | 2017 | 780 | 0.330 |
Why?
|
| Humans | 30 | 2025 | 43102 | 0.320 |
Why?
|
| Female | 21 | 2025 | 24698 | 0.320 |
Why?
|
| Male | 19 | 2025 | 23409 | 0.310 |
Why?
|
| Transcriptional Activation | 2 | 2006 | 173 | 0.300 |
Why?
|
| 5'-Nucleotidase | 3 | 2021 | 6 | 0.300 |
Why?
|
| Down-Regulation | 1 | 2011 | 456 | 0.290 |
Why?
|
| Kidney | 2 | 2011 | 372 | 0.280 |
Why?
|
| Etidronic Acid | 2 | 2018 | 4 | 0.270 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2006 | 1 | 0.250 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2006 | 5 | 0.250 |
Why?
|
| Sp1 Transcription Factor | 1 | 2006 | 46 | 0.250 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 934 | 0.250 |
Why?
|
| Elastin | 1 | 2006 | 40 | 0.240 |
Why?
|
| Blood Proteins | 1 | 2006 | 77 | 0.230 |
Why?
|
| Mutation, Missense | 3 | 2016 | 91 | 0.230 |
Why?
|
| Vibrissae | 2 | 2024 | 32 | 0.230 |
Why?
|
| Macrophages | 2 | 2021 | 529 | 0.230 |
Why?
|
| Cell Membrane | 4 | 2016 | 403 | 0.220 |
Why?
|
| Lymphangiogenesis | 1 | 2024 | 3 | 0.210 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 5 | 0.210 |
Why?
|
| Bone Marrow | 1 | 2024 | 35 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 131 | 0.210 |
Why?
|
| Osteogenesis | 2 | 2020 | 57 | 0.190 |
Why?
|
| Founder Effect | 1 | 2002 | 10 | 0.190 |
Why?
|
| Arteries | 2 | 2014 | 81 | 0.180 |
Why?
|
| Biopsy, Needle | 2 | 2018 | 59 | 0.180 |
Why?
|
| Genetics, Population | 1 | 2002 | 121 | 0.180 |
Why?
|
| Joint Diseases | 1 | 2021 | 5 | 0.170 |
Why?
|
| Adenosine Triphosphate | 2 | 2018 | 206 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2014 | 883 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2021 | 33 | 0.170 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 37 | 0.170 |
Why?
|
| Osteoblasts | 1 | 2020 | 44 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2018 | 863 | 0.160 |
Why?
|
| Organ Specificity | 3 | 2011 | 141 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2020 | 114 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2020 | 201 | 0.140 |
Why?
|
| Kidney Calculi | 1 | 2018 | 6 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 247 | 0.140 |
Why?
|
| Random Allocation | 1 | 2018 | 147 | 0.140 |
Why?
|
| Cell Aggregation | 1 | 2018 | 17 | 0.140 |
Why?
|
| Cholesterol | 1 | 2020 | 232 | 0.140 |
Why?
|
| Adenosine Diphosphate | 1 | 2018 | 21 | 0.140 |
Why?
|
| Bone Density Conservation Agents | 1 | 2018 | 28 | 0.140 |
Why?
|
| Mitochondria | 2 | 2020 | 523 | 0.140 |
Why?
|
| Alleles | 2 | 2016 | 352 | 0.140 |
Why?
|
| Species Specificity | 1 | 2018 | 286 | 0.140 |
Why?
|
| Transgenes | 1 | 2017 | 65 | 0.130 |
Why?
|
| Acute Disease | 1 | 2017 | 155 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 127 | 0.130 |
Why?
|
| Retrospective Studies | 2 | 2021 | 2544 | 0.130 |
Why?
|
| Adenosine | 2 | 2018 | 62 | 0.120 |
Why?
|
| Pedigree | 3 | 2008 | 94 | 0.110 |
Why?
|
| Myocardium | 2 | 2017 | 263 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1124 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 734 | 0.110 |
Why?
|
| Aorta | 2 | 2018 | 198 | 0.110 |
Why?
|
| Stroke | 1 | 2018 | 340 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 196 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1604 | 0.110 |
Why?
|
| Minerals | 1 | 2014 | 53 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2020 | 1621 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2017 | 549 | 0.100 |
Why?
|
| Osteopontin | 1 | 2014 | 46 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 81 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 78 | 0.100 |
Why?
|
| Rats | 1 | 2021 | 3735 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 1542 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2014 | 83 | 0.100 |
Why?
|
| Connective Tissue | 2 | 2017 | 7 | 0.100 |
Why?
|
| Biological Transport | 2 | 2011 | 204 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2013 | 80 | 0.090 |
Why?
|
| Haplotypes | 2 | 2003 | 197 | 0.090 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 11 | 0.090 |
Why?
|
| Administration, Oral | 2 | 2025 | 260 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2011 | 36 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2011 | 60 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 749 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1285 | 0.080 |
Why?
|
| INDEL Mutation | 1 | 2010 | 4 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2010 | 37 | 0.080 |
Why?
|
| Cell Line | 3 | 2013 | 1410 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 665 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2006 | 196 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 95 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2011 | 1271 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2018 | 1759 | 0.070 |
Why?
|
| Adult | 7 | 2020 | 13872 | 0.070 |
Why?
|
| Heterozygote | 1 | 2008 | 110 | 0.070 |
Why?
|
| Middle Aged | 7 | 2018 | 12222 | 0.070 |
Why?
|
| Skull | 2 | 2020 | 28 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 240 | 0.060 |
Why?
|
| Elastic Tissue | 1 | 2006 | 9 | 0.060 |
Why?
|
| Tropoelastin | 1 | 2006 | 14 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 58 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2011 | 735 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 314 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2006 | 37 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2025 | 54 | 0.060 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 40 | 0.060 |
Why?
|
| Eye | 1 | 2006 | 77 | 0.060 |
Why?
|
| Skin | 1 | 2006 | 187 | 0.060 |
Why?
|
| Aged | 5 | 2018 | 8214 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 92 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 2157 | 0.050 |
Why?
|
| Base Sequence | 1 | 2006 | 983 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2006 | 281 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2006 | 403 | 0.050 |
Why?
|
| South Africa | 1 | 2002 | 38 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2013 | 135 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2020 | 5 | 0.040 |
Why?
|
| Tibia | 1 | 2020 | 26 | 0.040 |
Why?
|
| Genotype | 1 | 2003 | 800 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1070 | 0.040 |
Why?
|
| Femur | 1 | 2020 | 47 | 0.040 |
Why?
|
| Lipase | 1 | 2020 | 20 | 0.040 |
Why?
|
| France | 2 | 2011 | 23 | 0.040 |
Why?
|
| Activin Receptors, Type I | 1 | 2018 | 3 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2018 | 9 | 0.040 |
Why?
|
| Insulin | 1 | 2020 | 258 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 389 | 0.040 |
Why?
|
| Urinalysis | 1 | 2018 | 34 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2018 | 80 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 80 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 59 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 5080 | 0.030 |
Why?
|
| Prevalence | 1 | 2002 | 1612 | 0.030 |
Why?
|
| Child | 1 | 2006 | 3443 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 183 | 0.030 |
Why?
|
| Phosphates | 1 | 2017 | 54 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 760 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 760 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1028 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 245 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 3994 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 473 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 861 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2011 | 1600 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 491 | 0.030 |
Why?
|
| Heart Valves | 1 | 2013 | 2 | 0.030 |
Why?
|
| Ventricular Function | 1 | 2013 | 8 | 0.030 |
Why?
|
| Systole | 1 | 2013 | 67 | 0.030 |
Why?
|
| Diastole | 1 | 2013 | 47 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2013 | 28 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 131 | 0.020 |
Why?
|
| Dogs | 1 | 2013 | 204 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 170 | 0.020 |
Why?
|
| Protein Folding | 1 | 2013 | 123 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2013 | 57 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 169 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 416 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 108 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2012 | 22 | 0.020 |
Why?
|
| Zebrafish | 1 | 2013 | 146 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 114 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 1772 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 163 | 0.020 |
Why?
|
| Colorimetry | 1 | 2012 | 53 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2853 | 0.020 |
Why?
|
| Compliance | 1 | 2011 | 14 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2011 | 28 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 429 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 53 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2011 | 39 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 65 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 183 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 236 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1568 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 317 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 15 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 440 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 92 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 40 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 667 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 238 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 455 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 592 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2003 | 32 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 138 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 278 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 3156 | 0.010 |
Why?
|
| Nucleotides | 1 | 2002 | 37 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 62 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 652 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 83 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 132 | 0.010 |
Why?
|
| Glutathione | 1 | 2002 | 171 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1180 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 695 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 592 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 1082 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1857 | 0.010 |
Why?
|